# Compass Therapeutics, Inc.: Form SC 13D/A, filed Nov 10, 2022

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: SC 13D/A
- Filed: 2022-11-10
- Accepted by EDGAR: Nov 10, 2022, 21:25 ET
- Period: not reported
- Accession: 0000947871-22-001162
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000094787122001162/ss1505016_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000094787122001162/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000094787122001162/ss1505016_sc13da.htm

Filed Nov 10, 2022.
Source: SEC EDGAR, the filing index for accession 0000947871-22-001162. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.